5-3-17 BioPharma-Reporter: “Latest Avid investment to turn bioreactor capacity up to 11,000L” Avid Bioservices will add multiple MilliporeSigma 2,000L bioreactors at its Californian single-use production plant in an effort to its increase annual revenue to over $100m. The Myford facility [Avid II] came online in Dec.2015, but continued demand for clinical & commercial biomanufacturing has led to a capacity upgrade. While an Avid spokesperson told Biopharma-Reporter the firm has experience with a “wide number of different single-use systems across multiple vendors,” this is the CMO’s first foray into the 2,000L scale... The investment will “bring total capacity within the Myford facility to over 9,000L of capacity at the 1,000 & 2,000L scale and the total capacity at our 2 facilities to over 11,000L,” we were told. Avid’s other facility is the Franklin plant, also located in Tustin, CA. “With the installation of the new bioreactors at Myford, we expect that facility, when operating in campaign mode, can exceed more than $75m annually. This would bring our total potential annual revenue across both of manufacturing facilities to well over $100m.” http://www.biopharma-reporter.com/Upstream-Processing/Avid-selects-MilliporeSigma-2-000L-single-use-bioreactors-at-CA-plant
= = = = = = = = = = 5-1-17/MPS-PR: MilliporeSigma Signs Biomanufacturing Deal with Avid Bioservices Avid Bioservices, a wholly-owned subsidiary of Peregrine Pharmaceuticals, reports that it will upgrade its Myford clinical and commercial manufacturing facility with multiple Mobius 2000L single-use bioreactors from MilliporeSigma. The new bioreactors, to be installed in mid-2017, will expand the company’s mfg. Capacity... “We ran a competitive process and chose the MilliporeSigma Mobius 2,000L single-use bioreactor system because it offers technical and ease of use advantages over competing single-use systems,” said Steven W. King, President, Avid Bioservices. “The confidence in the choice has only been further reinforced by our experience to date with the Mobius system up to the 1000L scale as part of a pilot program. Adding the Mobius technology to expand Avid’s Myford biomanufacturing capacity highlights our commitment to offer customers the latest single-use equipment and flexible solutions. The planned installation of MilliporeSigma’s Mobius 2000L bioreactors opens new opportunities for current and future Avid customers who require greater manufacturing capacity. We have already secured customer commitments for the 2,000L capacity as soon as it is installed in our Myford facility [Avid II] and believe the advanced technology it offers will be a key factor in continuing to grow our contract development and mfg. organization business.” King added that the first 2,000L pilot batch is planned for later this month. http://www.genengnews.com/gen-news-highlights/milliporesigma-signs-biomanufacturing-deal-with-avid-bioservices/81254281
3-13-17 CC, CEO Steve King: “...An important component of our Avid growth strategy is capacity expansion within our Myford facility. We are currently on track to install two 2,000-liter bioreactors [Mobius 2000L single-use] in the facility within the next few months, with a book of business for the reactors already in place. We believe the total capacity potential of the facility, when operating in campaign mode, can exceed more than $75mm annually, bringing us to well over $100mm in total potential revenue between our 2 mfg. facilities, providing us with adequate capacity to continue Avid revenue growth through FY’18. As we look beyond this FY and into the future, based on current operations & projected demand from our clients, we have also recently secured addl. space adjacent to our Myford facility, which we already have the use for as part of our growing operations. And additionally, would also allow us to further expand mfg. capacity based on committed business. While we will only begin converting space into mfg. capacity once client commitments and other necessary financing is in place, this puts us in an excellent position for continuing to grow the business beyond the coming FY.” http://tinyurl.com/grhwjvy
News 
Market Data 
Discover 
